κ receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum

Journal of Neurochemistry

Volumn 70, Issue 2, 1998, Pages 626-634

  Rawls, Scott M ^a   McGinty, Jacqueline F ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Glutamate; L trans Pyrrolidine 2,4 dicarboxylic acid; Microdialysis; Striatum; Opioid receptor

Indexed keywords

2,4 PYRROLIDINEDICARBOXYLIC ACID; CALCIUM CHANNEL; CALCIUM ION; GLUTAMIC ACID; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; KAPPA OPIATE RECEPTOR ANTAGONIST; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NORBINALTORPHIMINE;

AMINO ACID ANALYSIS; ANIMAL TISSUE; ARTICLE; CORPUS STRIATUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICRODIALYSIS; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0031936152     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70020626.x     Document Type: Article

References (53)

1. Chavkin C., James I. F., and Goldstein A. (1982) Dynorphin is a specific endogenous ligand of the κ-opioid receptor. Science 215, 413-415.
2. Church W. H. and Justice J. B. (1987) Rapid sampling and determination of extracellular dopamine in vivo. Anal. Chem. 59, 712-716.
3. de Montigny P., Stobaugh J. F., Givens R. S., Carlson R. G., Srinivasachar K., Sternson L. A., and Higuchi T. (1987) Naphthalene-2,3-dicarboxaldehyde/cyanide ion: a rationally designed fluorogenic reagent for primary amines. Anal. Chem. 59, 1096-1101.
4. Di Chiara G. and Imperato A. (1987) Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmacol. Exp. Ther. 244, 1067-1080.
5. Gannon R. L. and Terrian D. M. (1992) Kappa opioid agonists inhibit transmitter release from guinea pig hippocampal mossy fiber synaptosomes. Neurochem. Res. 17, 741-747.
6. Griffiths R., Dunlop J., Gorman A., Senior J., and Grieve A. (1994) L-trans-Pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable competitive inhibitors of the high-affinity glutamate transporters. Biochem Pharmacol. 47, 267-274.
7. Grudt T. J. and Williams J. T. (1993) Kappa-opioid receptors also increase potassium conductance. Proc. Natl Acad. Sci. USA 90, 11429-11432.
8. Heidbreder C. A., Goldberg S. R., and Shippenberg T. S. (1993) The kappa-opioid receptor agonist U-69593 attenuates cocaine-induced behavioral sensitization in the rat. Brain Res. 616, 335-338.
9. Herrera-Marschitz M., Meana J. J., O'Connor W. T., Goiny M., Reid M. S., and Ungerstedt U. (1992) Neuronal dependence of extracellular dopamine, acetylcholine, glutamate, aspartate, and gamma-aminobutyric acid (GABA) measured simultaneously from rat neostriatum using in vivo microdialysis: reciprocal interactions. Amino Acids 2, 157-179.
10. Hill M. and Brotchie J. (1995) Modulation of glutamate release by a kappa-opioid agonist in rodent and primate striatum. Eur. J. Pharmacol. 281, R1-R2.
11. Kalivas P. W. and Stewart J. (1991) Dopamine transmission in the initiation and expression of drug-and stress-induced sensitization of motor activity. Brain Res. 16, 223-224.
12. Kanemasa T., Asakura K., and Ninomiya M. (1995) Kappa-opioid agonist U50488 inhibits P-type calcium channels by two mechanisms. Brain Res. 702, 207-212.
13. Karler R., Calder L. D., Chaudry I. A., and Turkanis H. A. (1989) Blockade of 'reverse tolerance' to cocaine and amphetamine by MK-801. Life Sci. 45, 599-606.
14. Karler R., Calder L. D., Thai L. H., and Bedingfield J. B. (1994) A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine. Brain Res. 658, 8-14.
15. Kelley A. E. and Throne L. C. (1992) NMDA receptors mediate the behavioral effects of amphetamine infused into the nucleus accumbens. Brain Res. Bull. 29, 247-254.
16. Kuczenski R. and Segal D. S. (1997) Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J. Neurochem 68, 2032-2037.
17. Kusomoto K., Mackay K. B., and McCulloch J. (1992) The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia. Brain Res. 576, 147-151.
18. 3H]U-69593, a highly selective ligand for the opioid kappa receptor. Eur. J. Pharmacol. 109, 281-284.
19. Lason W., Simpson J. N., and McGinty J. F. (1989) The interaction between kappa-opioid agonist, U50,488H, and kainic acid: behavioral and histological assessments. Brain Res. 482, 233-239.
20. Maisonneuve I. M., Archer S., and Glick S. D. (1994) U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats. Neurosci. Lett. 181, 57-60.
21. Maneuf Y. P., Mitchell I. J., Crossman A., Woodruff G., and Brotchie J. (1995) Functional implications of kappa opioid receptor-mediated modulation of glutamate transmission in the output regions of the basal ganglia in rodent and primate models of Parkinson's disease. Brain Res. 683, 102-108.
22. Mansour A., Khachaturian M. E., Lewis M. E., Akil H., and Watson S. J. (1987) Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7, 2445-2464.
23. Mansour A., Fox C., Burke S., Meng F., Thompson R., Akil H., and Watson S. J. (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350, 412-438.
24. Mansour A., Burke S., Pavlic R. J., Akil H., and Watson S. J. (1996) Immunohistochemical localization of the cloned kappa, receptor in the rat CNS and pituitary. Neuroscience 71, 671-690.
25. Massieu L., Morales-Villagrán A., and Tapia R. (1995) Accumulation of extracellular glutamate by inhibition of its uptake is not sufficient for inducing neuronal damage: an in vivo microdialysis study. J. Neurochem. 64, 2262-2272.
26. McGinty J. F., Meshul C. K., Bohler W. T., Patterson T. A., and Chavkin C. (1995) Distribution of kappa opioid receptor immunoreactivity in basal ganglia: a light and electron microscopic study. Soc Neurosci. Abstr. 21, 1998.
27. Millan M. J. (1990) Kappa-opioid receptors and analgesia. Trends Pharmacol. Sci. 11, 70-76.
28. Morari M., O'Connor W. T., Ungerstedt U., and Fuxe K. (1993) N-Methyl-D-aspartic acid differentially regulates extracellular dopamine, GABA, and glutamate levels in the dorsolateral neostriatum of the halothane-anesthesized rat: an in vivo microdialysis study. J. Neurochem. 60, 1884-1893.
29. 3H U-69593 binding sites in rat brain: evidence for kappa opioid receptor subtypes. Eur. J. Pharmacol. 154, 27-34.
30. Nock B., Giordano L., Cicero T., and O'Connor L. (1990) Affinity of drugs and peptides for U-69,593-sensitive and -insensitive kappa opiate binding sites: the U-69,593-insensitive site appears to be the beta endorphin-specific epsilon receptor. J. Pharmacol. Exp. Ther. 254, 412-419.
31. O'Shea T., Weber P., Bammel B., Lunte C., and Lunte S. (1992) Monitoring excitatory amino acid release in vivo by microdialysis with capillary electrophoresis-electrochemistry. J. Chromatogr. 608, 189-195.
32. Parent A. and Hazrati L.-N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev. 20, 91-127.
33. Pierce R. C., Bell K., Duffy P., and Kalivas P. W. (1996) Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16, 1550-1560.
34. Portoghese P. S., Lipkwoski A. W., and Takemori A. E. (1987) Binaltorphimine and nor-binaltophimine, potent and selective kappa-opioid receptor antagonists. Life Sci. 40, 1287-1292.
35. Rawls S. M. and McGinty J. F. (1997) L-trans-Pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels are attenuated by calcium reduction, tetrodotoxin, and glutamate receptor blockade. J. Neurochem. 68, 1553-1563.
36. Reid M. S. and Berger S. P. (1996) Evidence for sensitization of cocaine-induced nucleus accumbens glutamate release. Neuroreport 7, 1325-1329.
37. Ruzicka B. B., Fox C. A., Thompson R. C., Meng F., Watson S. J., and Akil H. (1995) Primary astroglial cultures derived from several rat brain regions differentially express mu, delta, and kappa opioid receptor mRNA. Brain Res. Mol Brain Res. 34, 209-220.
38. Shippenberg T. S., Lefevour A., and Heidbreder C. A. (1995) Sensitization to the conditioned rewarding effects of cocaine: pharmacological and temporal characteristics. J. Pharmacol. Exp. Ther. 276, 545-554.
39. Simmons M. L. and Chavkin C. (1996) Kappa opioid receptor activation of a dendrotoxin-sensitive potassium channel mediates presynaptic inhibition of mossy fiber neurotransmitter release. Mol. Pharmacol. 50, 80-85.
40. Spanagel R., Herz A., and Shippenberg T. (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl Acad. Sci. USA 89, 2046-2050.
41. Tallent M., Dichter M. A., Bell G. I., and Reisine T. (1994) The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cell lines. Neuroscience 63, 1033-1040.
42. Terman G. W., Wagner J. J., and Chavkin C. (1994) Kappa opioids inhibit induction of long-term potentiation in the dentate gyrus of the guinea pig hippocampus. J. Neurosci. 14, 4740-4747.
43. 2 opioid receptors in rat and guinea pig brain. Brain Res. 562, 57-65.
44. Volterra A., Bezzi P., Rizzini B. L., Trotti D., Ullensvang K., Danbolt N., and Racagni G. (1996) The competitive transport inhibitor L-trans-pyrrolidine-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition. Eur. J. Neurosci. 8, 2019-2028.
45. Wagner J. J., Caudle R. M., and Chavkin C. (1992) Kappa-opioids decrease excitatory transmission in the dentate gyrus of the guinea pig hippocampus. J. Neurosci. 12, 132-141.
46. Waldmeier P. C., Wicki P., and Feldtrauer J. (1993) Release of endogenous glutamate from rat cortical slices in the presence of the glutamate uptake inhibitor L-trans-PDC-2,4-dicarboxylic acid. Naunyn Schmiedbergs Arch. Pharmacol. 348, 478-485.
47. Weisskopf M. G., Zalutsky R. A., and Nicoll R. A. (1993) The opioid peptide dynorphin mediates heterosynaptic depression of hippocampal mossy fibre synapses and modulates long-term potentiation. Nature 362, 423-427.
48. White F. and Wolf M. E. (1991) Psychomotor stimulants, in The Biological Bases of Drug Tolerance and Dependence (Pratt J., ed), pp. 154-197. Academic Press, San Diego.
49. Wolf M. E. and Jeziorski M. (1993) Coadministration of MK-801 with amphetamine, cocaine, or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res. 613, 291-294.
50. Xue C.-J., Ng J. P., Li Y., and Wolf M. E. (1996) Acute and repeated systemic amphetamine administration: effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J. Neurochem. 67, 352-363.
51. Yamamoto B. K. and Cooperman M. A. (1994) Differential effects of chronic antipsychotic drug treatment on extracellular glutamate and dopamine concentrations. J. Neurosci. 14, 4159-4166.
52. Yamamoto B. K. and Davy S. (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J. Neurochem. 58, 1736-1742.
53. 2 opioid receptors. Proc. Natl. Acad. Sci. USA 85, 4061-4065.